ASC30 Tablets A1

· Ascletis Pharma (China) Co., Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC30 Tablets A1, covering 2025-05-20 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity [Phase 1]

See pricing